My Next Health (MNH) is an innovative healthcare company that is revolutionizing the global healthcare sector through the power of actionable genomics. With a vision to improve healthcare outcomes, MNH deploys an innovative genomic-based AI and quantum platform for clinical trials, point of care solutions, and personalized consumer health. MNH's proprietary insights focus on the intricate interactions between systems of genes and epigenetic factors such as environment, lifestyle, and nutrition, to drive essential metabolic pathways.

These groundbreaking discoveries stem from over 15,000 case studies conducted by Dr. Mansoor Mohammed, MNH's Chief Scientific Officer, a renowned geneticist, whose research collaboration was short-listed for a Nobel Prize in Physiology/Medicine for the discovery of copy number variation in genetics. To make their insights more accessible, MNH is scaling their operations through a cutting-edge tier 1 generative AI platform.

This platform utilizes exponential technologies, including quantum computing, to revolutionize personalized healthcare. From drug discovery and development to point of care solutions and consumer applications, MNH is spearheading a new paradigm for healthcare. Experience the future of healthcare with MNH